Edwards Lifesciences upgraded to Buy from Hold at Stifel
Stifel analyst Rick Wise upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $90, up from $75. The firm said that TAVR, ...
Stifel raises Edwards Lifesciences stock to buy, target to $90
Stifel analysts upgraded Edwards Lifesciences (NYSE:EW) stock from Hold to Buy, citing potential growth acceleration in the Transcatheter Aortic Valve Replacement (TAVR) market. The firm also ...
Crowdfund Insider23h
OurCrowd Recognized Again as Most Active Venture Investor in Israel, Once Again: 68 Exits to Date
Online investment platform OurCrowd has once again been recognized as the most active venture investor in Israel - which ...
This Coca-Cola Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Jefferies analyst Kaumil Gajrawala upgraded the rating for The Coca-Cola Company KO from Hold to Buy and increased the price target from $69 to $75. Coca-Cola shares closed at $62.83 on Wednesday. See ...
Indiatimes15h
Cadila Healthcare Share Price Returns
Bonus Apr 05, 2010 Apr 06, 2010 Feb 25, 2010 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Aug 30, 2006 Aug 31, 2006 Apr 28, 2006 Bonus Ratio: 1 share(s) for every 1 shares held Zydus ...
Indiatimes17h
Supriya Lifescience Share Price
Supriya Lifescience Ltd., incorporated in the year 2008, is a Large Cap company (having a market cap of Rs 5,336.41 Crore) operating in Pharmaceuticals sector. Supriya Lifescience Ltd. key ...